Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Down Following Weak Earnings
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) gapped down before the market opened on Tuesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $610.86, but opened at $561.75. Regeneron Pharmaceuticals shares last traded at $558.22, with a volume of 229,725 shares trading hands. The biopharmaceutical […]
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) gapped down before the market opened on Tuesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $610.86, but opened at $561.75. Regeneron Pharmaceuticals shares last traded at $558.22, with a volume of 229,725 shares trading hands. The biopharmaceutical […]
